Patient Education Resources
Having a conversation with your diabetes care team about new type 1 diabetes therapy options can be overwhelming. These resources were designed to assist you in having an informed discussion and help you feel more confident.
Early Detection and Monitoring
You know the phrase “knowledge is power”? That’s what you gain when you or a family member gets screened for type 1 diabetes (T1D). Thanks to recent medical breakthroughs, when you detect T1D early you gain time to prepare for future needs—and may even be able to delay the need for insulin therapy.
Disease-Modifying Therapies
Disease-modifying therapies (DMTs) are treatments that aim to slow down or stop the autoimmune attack on beta cells, helping keep them healthy longer and delaying the progression of T1D. Early in your diagnosis, if you are producing enough C-peptide, there may be treatment options available to preserve the cells that are still making insulin.
Understanding C-peptide
C-peptide is a useful indicator of how much insulin your body is still making, and where you are in the progression of type 1 diabetes. Learn more about how C-peptide is measured and its role in clinical trials for disease-modifying therapies.
Cell Therapies
Islet cell therapies replace the insulin-producing cells that are destroyed by the immune system in people with type 1 diabetes. The islet cells may be obtained from deceased organ donors or manufactured in a well-controlled laboratory environment.
Living With T1D
SGLT2 inhibitors
People with type 1 diabetes have increased risks of kidney and heart complications. Sodium-Glucose Co-Transporter 2 (SGLT2) inhibitors are medications that promote excess glucose excretion in the urine and have demonstrated positive effects on the heart and kidneys in people with T1D. SGLT2 inhibitors can help reduce the risk of these complications developing or getting worse.
Type 1 Diabetes News
and Updates
Discover stories from Breakthrough T1D about our research, advocacy, initiatives, and supporters.
